Leukemia, Promyelocytic, Acute
"Leukemia, Promyelocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
Descriptor ID |
D015473
|
MeSH Number(s) |
C04.557.337.539.275.700
|
Concept/Terms |
Leukemia, Promyelocytic, Acute- Leukemia, Promyelocytic, Acute
- Leukemia, Acute Promyelocytic
- Leukemia, Myeloid, Acute, M3
- M3 ANLL
- ANLL, M3
- Myeloid Leukemia, Acute, M3
- Progranulocytic Leukemia
- Promyelocytic Leukemia, Acute
- AML M3
- Acute Promyelocytic Leukemia
- Acute Promyelocytic Leukemias
- Leukemia, Progranulocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Promyelocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Promyelocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Promyelocytic, Acute" by people in this website by year, and whether "Leukemia, Promyelocytic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 2 | 3 |
1996 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 2 | 0 | 2 |
2005 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Promyelocytic, Acute" by people in Profiles.
-
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia. JCO Oncol Pract. 2021 04; 17(4):e497-e505.
-
Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet. 2017 May; 49(5):742-752.
-
All-trans retinoic acid syndrome: another cause of drug-induced respiratory failure. South Med J. 2007 Sep; 100(9):899-902.
-
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
-
Acute promyelocytic leukemia, microgranular variant. Blood. 2004 Aug 01; 104(3):605.
-
Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
-
Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis. Leukemia. 2003 May; 17(5):919-24.
-
HLA-Dr negative acute non-lymphocytic leukemia. Ann Clin Lab Sci. 1998 May-Jun; 28(3):150-2.
-
The biologic function of PML and its role in acute promyelocytic leukemia. Leuk Lymphoma. 1996 Oct; 23(3-4):277-85.
-
Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood. 1995 Nov 01; 86(9):3535-41.